Jason Hoitt serves as Executive at Dova Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Jason Hoitt has executed 10 insider transactions totaling $305.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 10, 2023 involved selling 4,500 shares valued at $45.0K.
Jason Hoitt currently holds 4,500 shares of Dova Pharmaceuticals Inc. (DOVA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason Hoitt has been a net seller of DOVA stock. They have purchased $24.4K and sold $281.4K worth of shares.
Jason Hoitt's most recent insider trade was on Feb 10, 2023, when they sold 4,500 shares at $10.00 per share.
Get notified when new Form 4 filings are submitted
| $5.43 |
| Discretionary |
| Nov 12, 2019 | DOVA | $0 | Disposition | 9,970 | $N/A | Discretionary |
| Sep 30, 2019 | DOVA | $66.8K | Sale | 2,387 | $28.00 | Discretionary |
| Jul 15, 2019 | DOVA | $14.8K | Sale | 900 | $16.44 | Discretionary |
| Jul 15, 2019 | DOVA | $100.9K | Sale | 6,680 | $15.10 | Discretionary |
| Jun 28, 2019 | DOVA | $2.2K | Sale | 150 | $14.40 | Discretionary |
| Jun 28, 2019 | DOVA | $30.8K | Sale | 2,237 | $13.77 | Discretionary |
| Apr 8, 2019 | DOVA | $20.9K | Sale | 2,387 | $8.77 | Discretionary |
| Dec 19, 2018 | DOVA | $0 | Award | 24,711 | $N/A | Discretionary |